Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer - Laboratory Investigation
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth | Oncogene
HER2 evaluation by immunohistochemistry and fluorescence in situ... | Download Scientific Diagram
Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers | British Journal of Cancer
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Initial criteria for ERBB2 determination of immunohistochemistry scores... | Download Scientific Diagram
HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer | Scientific Reports
Cancers | Free Full-Text | Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
Cancers | Free Full-Text | Transcriptomic Changes Associated with ERBB2 Overexpression in Colorectal Cancer Implicate a Potential Role of the Wnt Signaling Pathway in Tumorigenesis
DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2- positive breast cancer cells
Frontiers | Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort
Prognostic value of c-erbB2 oncoprotein expression in 117 patients with... | Download Table
Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation | Modern Pathology
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials - The Lancet Oncology
HER2/neu testing in primary colorectal carcinoma | British Journal of Cancer
The frequency distribution of staining intensity of c-erbB-2 protein of... | Download Scientific Diagram
Cancers | Free Full-Text | Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients
A schematic overview of HER2 scoring in breast cancer, as used in this... | Download Scientific Diagram
![PDF] Human Epidermal Growth Factor Receptor Family ( HER ) in Gastric Cancer 143 involvement in the progression of gastric cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/302bf8eea17d6a77f47dfc7ebb7c4f27c825285b/8-Table1-1.png "PDF] Human Epidermal Growth Factor Receptor Family ( HER ) in Gastric Cancer 143 involvement in the progression of gastric cancer | Semantic Scholar")
PDF] Human Epidermal Growth Factor Receptor Family ( HER ) in Gastric Cancer 143 involvement in the progression of gastric cancer | Semantic Scholar
Clinicopathological variables according to c-erbB2 status... | Download Table
Recommended ERBB2 (HER2/neu) scoring algorithm for immunohistochemistry... | Download Scientific Diagram
Pathology Outlines - HER2 (c-erbB2) breast
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond - ScienceDirect
